Effects of gabapentin on anxiety induced by simulated public speaking

Journal of Psychopharmacology

Volumn 17, Issue 2, 2003, Pages 184-188

  De Paris, Fernanda ^b   Sant'Anna, Marcia K ^b   Vianna, Monica R M ^b   Barichello, Tatiana ^a   Busnello, Joao V ^b   Kapczinski, Flavio ^b   Quevedo, Joao ^a   Izquierdo, Ivan ^b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Anxiety; Gabapentin; Simulated public speaking

Indexed keywords

GABAPENTIN; PLACEBO;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DEPRESSION; DRUG CAPSULE; HEADACHE; HEART RATE; HOSTILITY; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SELF EVALUATION; SOMNOLENCE; SPEECH; TREATMENT OUTCOME; VERTIGO; VISUAL ANALOG SCALE;

ACETIC ACIDS; ADOLESCENT; ADULT; AMINES; ANTI-ANXIETY AGENTS; ANXIETY; BLOOD PRESSURE; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; MALE; SPEECH;

EID: 0038677028     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881103017002006     Document Type: Article

References (24)

1. Bond A J, Lader M H (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211-218
2. Brown J P, Gee N S (1998). Cloning and deletion mutagenesis of the α2δ calcium channel subunit from porcine cerebral cortex. J Biol Chem 273: 25458-25465
3. Chouinard G, Beauclair L, Belanger M C (1998). Gabapentin: longterm antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can J Psychiatry 43: 305
4. de-Paris F, Busnello J V, Salgeuiro J B, Quevedo J, Izquierdo I, Kapczinski F (2000) The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behav Pharmacol 11: 169-173
5. Erfurth A, Kammerer C, Grunze H, Normann C, Walden J (1998). An open label study ofgabapentin in the treatment of acute mania. J Psychiatr Res 32: 261-264
6. Gee N S, Brown J P, Dissanayake V U K, Offord J, Thurlow R, Woodruff G N (1996). The novel anticonvulsant drug, gabapentin (neurontin), binds to the α2δ subunit of a calcium channel. J Biol Chem 271: 5768-5776
7. Ghaemi S N, Katzow J J, Desai S P, Goodwin F (1998) Gabapenin treatment of mood disorders: a preliminary study. J Clin Psychiatry 59: 426-429
8. Guimarães F S, Kohem C L, Gus G, Fillmann H S, de-Vecino M C A, de-Paoli C L, Ribeiro M A S (1989) A simple simulated public speaking test for evaluated anxiolytic drugs. Braz J Med Res 22: 1083-1089
9. Guimarães F S, Mbaya P S, Deakin J F W (1997) Ritanserin facilitates anxiety in a simulated public speaking. J Psychopharmacol 11: 225-231
10. Hetem L A B, de-Souza C J, Guimarães F S, Zuardi A W, Graeff F G (1993) D-fenfluramine reduces anxiety induced by simulated public speaking. Braz J Med, Res 26:971-974
11. Honmou O, Oyelese A A, Kocsis J D (1995). The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res 692: 273-277
12. Kapczinski F, Curran H V, Gray J, Lader M (1994) Flumazenil has na anxiolytic effect in simulated stress. Psychopharmacology 114:187-189
13. McNair D M, Frankenthaler L M, Czerlinsky T, White T W, Sasson S, Fischer S (1982) Simulated public speaking as a model of clinical anxiety. Psychopharmacology 77: 7-10
14. McNair D M, Lorr M, Droppleman L F (1988) Manual for the profile of mood states. Educational and Industril Testing Service, San Diego, CA
15. Mellick G A, Mellicy L B, Mellick J D (1995). Gabapentin in the management of reflex sympathetic dystrophy. J Pain Sympt Man 10: 265-266
16. Monteiro-dos-Santos P C, Graeff F G, dos-Santos J E, Ribeiro R P P, Guimarães F S, Zuardi A W (2000) Effects of tryptophan depletion on anxiety induced by simulated public speaking. Braz J Med Res 33: 581-587
17. Pande A C, Polack M H, Crockatt J, Greiner M, Chouinard G, Lydiard R B, Taylor C B, Dager S R, Shiovitz T (2000) Placebo-Controled Study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 20: 467-471
18. Pollack M H, Matthews J, Scott E L (1998) Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry 155: 992-993
19. Radulovic L L, Turck D, von Hodenberg A, Vollner K O, McNally W P, Dettart P D, Hanson B J, Bockbrader H N, Chang T (1995). Disposition of gabapentin (Neurontin) in mice, dogs, rats and monkeys. Drug Metab Dispos 23: 441-448
20. Ryback R, Ryback L (1995). Gabapentin for behavioral dyscontrol. Am J Psychiatry 152: 1399
21. Schaffer C B, Schaffer L C (1997). Treatment of acute mania with gabapentin. Am J Psychiatry 154: 291-292
22. Singh L, Field M J, Ferris P, Hunter J C, Oles R J, Williams R G, Woodruff G N (1996). The antiepileptic agent gabapentin (Neurontin) possess anxiolytic-like and antinociceptive actions that are reversed by D-Serine. Psycbopharmacology 127:1-9
23. Stanton S P, Keck P E Jr, McElroy S L (1997) Treatment of acute mania with gabapentin. Am J Psychiatry 154:287
24. 3H]gabapentin binding to a novel site in the rat brain: homogenate binding studies. Eur J Pharmacol (Mol Pharmacol Sec) 244: 293-301